Metabolic-Fit / 100
Freya Meds review
Three clearly labeled commitment tiers per molecule — Monthly at $297/mo semaglutide and $390/mo tirzepatide, with cheaper Quarterly and Annual prepay options — undercut by homepage marketing that headlines the deepest-commitment $150/mo annual rate, a named clinician's title that doesn't match her own bio, and a 450,000-patient reach claim that's self-reported rather than verified.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Freya Meds at a glance
- Semaglutide
- $297/mo
- Tirzepatide
- $390/mo
- Coverage
- 50 states (self-reported; no exclusion list published)
- Brand-name
- Compounded only
How we scored Freya Meds
Each factor is scored from Freya Meds's real pricing, disclosures and oversight, then combined into the 48/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Limited public detail on who oversees care and how.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- freyameds.com
Verified via direct fetch of freyameds.com and freyameds.com/pricing (2026-08-04); no browser walkthrough or account creation was completed. Compounded-only: marketed as "same active ingredient as Ozempic®/Wegovy®" (semaglutide) and "same active ingredient as Mounjaro®/Zepbound®" (tirzepatide). Three unambiguous, clearly-labeled commitment tiers per molecule on /pricing: semaglutide Annual $150/mo, Quarterly $250/mo, Monthly $297/mo; tirzepatide Annual $249/mo, Quarterly $333/mo, Monthly $390/mo. The homepage's "starting as low as $150/month" marketing anchors on the Annual (deepest-commitment) tier, not the standing Monthly rate. Two named clinicians: Dr. Sienna Steckel (titled "Lead Physician" but described in the same sentence as an NP with 8 years of GLP-1 experience — a title inconsistency, recorded rather than resolved) and Dr. Christopher Findley ("Consulting Physician"). Homepage claims "450,000+ patients across 50 U.S. states" — a self-reported reach claim, not independently verified. The standard compounded/not-FDA-approved disclaimer sentence was not found verbatim on the pages checked in this fetch.
What to expect when you sign up
We walked Freya Meds's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Homepage and /pricing list three commitment tiers per molecule — Annual, Quarterly, Monthly — each clearly labeled with its own price; no toggle or guesswork needed to read them
- 2The homepage anchors its marketing on the Annual (12-month prepay) rate — "Plans from as little as $150/month" — rather than the no-commitment Monthly rate
- 3A "Meet Your Care Team" section names two clinicians directly on the page
What we noticed
- One named clinician is titled "Lead Physician" in the role label but described in the same sentence as an NP with 8 years of GLP-1 experience — a title inconsistency we're flagging rather than silently resolving either way
- Claims "450,000+ patients across 50 U.S. states" on its homepage — a first-party marketing claim, not independently verified beyond the site's own text
- We did not find the standard "not FDA-approved, compounded" disclaimer sentence verbatim on the pages we checked — that means we didn't see it, not that it isn't there
- We did not create an account or reach checkout — pricing above comes from the public /pricing page, not a completed signup
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $297 | Monthly (no commitment) |
| Compounded semaglutide | $250 | Quarterly planBilled quarterly — a deeper commitment than the no-commitment monthly rate. |
| Compounded semaglutide | $150 | Annual plan (12-month prepay)The rate its homepage headlines as "starting as little as $150/month" — this is the deepest-commitment, 12-month prepay tier, not the ongoing no-commitment price. |
| Compounded tirzepatide | $390 | Monthly (no commitment) |
| Compounded tirzepatide | $333 | Quarterly planBilled quarterly. |
| Compounded tirzepatide | $249 | Annual plan (12-month prepay)12-month prepay tier. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Freya Meds's public disclosures at last review and change often; confirm the current number on Freya Meds's own site.
What we like
- Three clearly labeled commitment tiers per molecule on its own pricing page, with no ambiguous toggle state to guess at
- Unlimited doctor consultations, monthly group calls, and a one-on-one dietitian consultation bundled into every tier, per its own site
- States "Cancel anytime" on its pricing page
- Names two clinicians directly on a team page rather than leaving oversight anonymous
The caveats
- The homepage's headline "$150/month" marketing figure is the deepest-commitment, 12-month prepay rate — the no-commitment monthly price is $297/mo semaglutide, $390/mo tirzepatide
- One named clinician's title is inconsistent on its own page — labeled "Lead Physician" but described as a nurse practitioner in the same sentence
- Its "450,000+ patients across 50 states" reach claim is self-reported marketing copy, not independently verified
- We could not find the standard compounded/not-FDA-approved disclaimer sentence on the pages checked
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
- Compounded only — no brand-name option and no oral form
Freya Meds for mothers: our verdict
Three clearly labeled commitment tiers per molecule — Monthly at $297/mo semaglutide and $390/mo tirzepatide, with cheaper Quarterly and Annual prepay options — undercut by homepage marketing that headlines the deepest-commitment $150/mo annual rate, a named clinician's title that doesn't match her own bio, and a 450,000-patient reach claim that's self-reported rather than verified. It runs about $250/month, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh Freya Meds the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a generic weight-loss review skips.
What Freya Meds actually costs
- Compounded semaglutide — Monthly (no commitment): $297/mo
- Compounded semaglutide — Quarterly plan: $250/mo
- Compounded semaglutide — Annual plan (12-month prepay): $150/mo
- Compounded tirzepatide — Monthly (no commitment): $390/mo
- Compounded tirzepatide — Quarterly plan: $333/mo
- Compounded tirzepatide — Annual plan (12-month prepay): $249/mo
For context, the typical ongoing price across our roster is around $174/month, so Freya Meds sits at the premium end.
The medications Freya Meds prescribes
Freya Meds prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Freya Meds fits — and where it doesn't — for mothers
A good fit if…
- you want a real clinician reading your history around postpartum and breastfeeding timing, not an auto-approving quiz.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you want frictionless cancellation — read the cancellation and refund terms in the caveats above before you pay.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Freya Meds is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers comfortable prepaying a full year for the lowest number, who want unlimited consultations, group calls and a dietitian bundled into every tier.
Alternatives to Freya Meds
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Freya Meds
Head-to-head & alternatives
Freya Meds, answered
- Is Freya Meds' $150/month price the real ongoing rate?
- No — that's the Annual plan, paid 12 months upfront. The no-commitment Monthly rate, which is what most new patients actually pay before deciding to commit longer, is $297/mo for semaglutide and $390/mo for tirzepatide. A Quarterly tier sits in between at $250/mo and $333/mo.
- Who prescribes at Freya Meds?
- Two named clinicians appear on its "Meet Your Care Team" page: Dr. Sienna Steckel and Dr. Christopher Findley. Worth knowing: Dr. Steckel is labeled "Lead Physician" in the role title but described in the same sentence as a nurse practitioner with 8 years of GLP-1 experience — an inconsistency on Freya's own page that we're recording rather than resolving for you.
- Does Freya Meds serve my state?
- It claims "450,000+ patients across 50 U.S. states" on its homepage, but that's a self-reported marketing figure, and we found no published state-exclusion list to check it against. Confirm your own state directly with Freya Meds before paying.
Pricing, states and verification reflect Freya Meds's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.